1 / 4
Etrebelle PN
Pack contents: 1 vial × 436.8 mg
Composition: (PLA: 150 mg + PN 35 mg + HA: 15 mg)
Manufacturer: BR Pharm Co., Ltd., South Korea
$135.00 USD
Enquire about this productPrice excludes shipping. Availability and supply conditions are confirmed individually.
Etrebelle PN is a vial product combining polylactic acid, polynucleotides and hyaluronic acid. The supplier lists a 436.8 mg vial and separately identifies 150 mg PLA, 35 mg PN and 15 mg HA; those three amounts are only part of the stated total.
The original images may contain text in another language. The product summary and details are available in your selected language.
Etrebelle PN is a vial product combining polylactic acid, polynucleotides and hyaluronic acid. The supplier lists a 436.8 mg vial and separately identifies 150 mg PLA, 35 mg PN and 15 mg HA; those three amounts are only part of the stated total.
- Listed components: PLA 150 mg; PN 35 mg; HA 15 mg
- 1 vial × 436.8 mg
- Manufacturer (listed)
- BR Pharm
- Composition
- Listed components: PLA 150 mg; PN 35 mg; HA 15 mg
- Product format
- Vial
- Pack contents
- 1 vial × 436.8 mg
The named components total 200 mg, while the listed vial mass is 436.8 mg. The remaining ingredients and their amounts are not confirmed here.
For qualified professional use. Check the instructions supplied with the exact product and applicable local requirements before use.
Sources & review date
- Derma Solution — Etrebelle PNRetailer
Information reviewed . Source references describe the named product; the supplied label identifies its exact version and market.
Contact our team to share feedback about your purchase or ask about current offers.
